Founded in 1990, the International Myeloma Foundation (IMF) is the oldest and largest myeloma organization, reaching more than 200,000 members in 113 countries worldwide. Dedicated to improving the quality of life of myeloma patients and their families while working toward prevention and a cure, the IMF focuses in four key areas: research, education, support and advocacy. As the leader in innovative and globally collaborative myeloma research, the IMF brings together the world's leading experts in the most successful and unique way through the International Myeloma Working Group (IMWG) and the Black Swan Research Initiative, which is charting the course to a cure, mentoring the next generation of innovative investigators, and improving lives through better care.
Program names and associated costs are listed for the top programs as reported on the charity's most recently filed Form 990. The top programs displayed will include the largest three programs, or those programs covering at least 60% of the charity's total expenses, whichever comes first.
Independent - the organization is an independent organization or an independent auxiliary (i.e., not affiliated with a National, Regional, or Geographic grouping of organizations).
This tool is not for questions about Charity Navigator, such as how we derived this charity’s rating. We will happily answer those questions if you contact us directly. Likewise, if you have questions for this charity, then we encourage you to contact the charity directly (we include the charity’s contact information in the upper left-hand corner of this page) since few charities regularly monitor this commenting tool.
Founded in 1990, the International Myeloma Foundation (IMF) is the oldest and largest myeloma organization, reaching more than 200,000 members in 113 countries worldwide. Dedicated to improving the quality of life of myeloma patients and their families while working toward prevention and a cure, the IMF focuses in four key areas: research, education, support and advocacy. As the leader in innovative and globally collaborative myeloma research, the IMF brings together the world's leading experts in the most successful and unique way through the International Myeloma Working Group (IMWG) and the Black Swan Research Initiative, which is charting the course to a cure, mentoring the next generation of innovative investigators, and improving lives through better care.
For 12 years, the IMF has received a 4-star rating based on Charity Navigator's previous methodology. In 2016, Charity Navigator developed a new methodology for rating charities. Under the new methodology, 90 points are required for a 4-star rating and the IMF is less than one point away from a 4-star status. The change in the IMF's rating from 4-stars to 3-stars is due to Charity Navigator's new Liabilities to Assets Ratio metric, which measures an organization's total liabilities against its total assets. For the IMF, 95% of the liabilities balance relates to deferred revenue. The IMF's deferred revenue is comprised of fully executed contracts which are recognized as income as the program expenses occur. For the IMF, the deferred revenue balance provides insight into committed program support. We look forward to your continued support. Thank you very much.
Charity Contact Info
International Myeloma Foundation
12650 Riverside Drive
Suite 206 North Hollywood,
CA 91607
tel: (800) 452-2873 fax: (818) 487-7454 EIN: 95-4296919
